
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Why most Jewish Israelis back the death penalty for terrorists - 2
Raw oysters linked to ongoing salmonella outbreak infecting 64 across 22 states: CDC - 3
Dozens killed as Angola flood death toll rises - 4
South African radio presenter among five charged over Russia recruitment plot - 5
Norovirus infections increase significantly, with positive test rates reaching 14%
Smartwatches: Remain Associated and Dynamic
The Electric Toyota Hilux Is Finally here, But It's Not Cheap
From candy cane fishing to ornament switcharoo, here are some of the best games you can play with your loved ones this holiday season
Mechanical Sidekick d: A Survey of \Elements and Execution d\ Cell phone
Europe’s EV Boom Was Real in 2025. The Real Fight Starts In 2026
Picking the Right Doctor prescribed Medication Inclusion in Senior Protection.
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
Jennifer Lawrence and Josh Hutcherson to reprise their roles for new 'Hunger Games' movie 'Sunrise on the Reaping'
Building an Individual Brand: Illustrations from Powerhouses











